Herit X
Herit X
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Herit X? Learn more here.
About this organization
Mission
Our mission is to accelerate the discovery and development of new medicines that prevent cancer. Our strategy is to support research on prevention of inherited cancers as a path towards elimination of all cancers.
About
The HeritX mission is to prevent inherited cancers. The first program, launched in 2015, is the Global HeritX Initiative to Prevent Inherited BRCA Cancers (The HeritX Initiative), which was publicly launched in November 2015 with a Banbury Conference at Cold Spring Harbor Laboratory. This meeting resulted in the first research and development (R&D) roadmap to prevent inherited BRCA cancer. Following the conference, HeritX connected with more than 200 research groups to identify ideas to prevent BRCA cancers, and selected the most promising ideas for HeritX to support. HeritX's work includes enabling ongoing projects, initiated in 2017 and 2018. One of these projects, which involves an international collaborative cancer prevention vaccine project at the Netherlands Cancer Institute, Dana-Farber Cancer Institute, Johns Hopkins University and ISA Pharmaceuticals. In addition, HeritX released a global request for new BRCA cancer prevention research proposals in 2018 and received new research proposals. Final selection of new projects for funding will happen in 2019 following external peer review. Information about HeritX's grant program and grant selection process can be found at https://www.heritx.org/faq/.
Interesting data from their 2019 990 filing
The filing sets forth the mission of the non-profit as “Heritx, inc. is a nonprofit corporation formed with the stated mission of preventing inherited cancer by raising awareness and providing resources and expertise to promote research and innovation for development of therapies for the prevention of inherited cancers. heritx's strategy is to convene leading experts worldwide in the field of cancer research, facilitate the exchange of ideas and collaboration, and coordinate, design, direct, and fund research efforts to accelerate the achievement of cancer prevention.”.
When detailing its responsibilities, they were listed as: “Heritx is a nonprofit corporation formed with the stated mission of preventing inherited cancer.”.
- The state in which the non-profit is legally permitted to operate is DE.
- The address of the non-profit for 2019 according to the filing is 1217 Wilshire Blvd, Santa Monica, CA, 90403.
- The number of employees reported by the non-profit on their form as of 2019 is 5.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is $662,620.
- The organization has 6 independent voting members.
- The organization was formed in 2015.
- The organization pays $357,509 in salary, compensation, and benefits to its employees.
- The organization pays $113,515 in fundraising expenses.
Additional Non-Profits in the area
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.